🇺🇸 FDA
Patent

US 10617681

1-arylalkyl-4-acylaminopiperidine compounds

granted A61KA61K31/16A61K31/4465

Quick answer

US patent 10617681 (1-arylalkyl-4-acylaminopiperidine compounds) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/16, A61K31/4465, A61K31/4468, A61K31/451